Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Xhail Completes Shares Issues, Closes Acquisition and Registers New Name

30 July, 2020Share Issues Xhail AB (publ) (“Xhail” or the “Company”) (formerly known as IFOX Investments AB (publ)) has completed the right issue (the “Rights Issue”) at full subscription as well as a directed share issue (the “Directed Share Issue”), raising a total amount of SEK 28 616 874.00 by issuing a total of 238 473 950 shares at a price of SEK 0.12 per share. The Rights Issue and the Directed Share Issue were registered at the Swedish Companies’ Registration Office (Sw: Bolagsverket) on July 21[st] 2020. The total number of shares in the Company after registration is 308 225

Invitation: Press and analyst conference

Holmen’s interim report for January–June 2020 will be published at lunchtime on Thursday 13 August. In view of this, you are invited to watch the online broadcast of our press and analyst conference on the same day at 14.30 CEST. Time: 13 August at 14.30 CESTOnline broadcast: www.holmen.com/reports Holmen President and CEO Henrik Sjölund, together with CFO Anders Jernhall, will present and comment on the report. The presentation will be held in English. You may also participate in the conference by telephone, by calling: +46 8 505 583 52 (within Sweden)+44 333 300 92 74 (

Eisai presents the latest data from the Phase 2b open-label extension study of BAN2401 at AAIC 2020

Stockholm, July 30, 2020 – BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that the company’s partner Eisai presented the latest data from the open-label extension of the Phase 2b study with the investigational BAN2401 in early Alzheimer’s disease. The preliminary results show, among other things, a continuous decrease in amyloid levels in the brain measured at three, six and twelve months with BAN2401 treatment in those patients who had previously received placebo. The frequency of amyloid-related imaging abnormalities-edema (ARIA-E) during BAN2401 treatment to date in the

Systemair´s Annual General Meeting on 26 August 2020

Press Release, 30 July 2020 Systemair AB (publ) (NASDAQ OMX Stockholm: SYSR) with broken fiscal year 1 May to 30 April, the Annual General Meeting will be held on Wednesday, 26 August 2020 at 3 p.m. in the auditorium, Systemair Expo, in Skinnskatteberg. Convening notice to the Annual General Meeting, the proposed agenda and the proposed decisions in its entirety, is attached to this press release and published on the company's website group.systemair.com. On the website there is also a proxy form and the ability to sign up for participation in the Annual General Meeting. The notice of

NoHo Partners Plc's Q2/2020 Half-year Report briefing on 11 August 2020 at 10 a.m. at Löyly

NoHo Partners Plc INVESTOR NEWS 30 July 2020 at 11:00 NoHo Partners Plc's Q2/2020 Half-year Report briefing on 11 August 2020 at 10 a.m. at Löyly NoHo Partners Plc will publish its Half-year Report for January 1 - June 30, 2020 on Tuesday, August 11, 2020 approximately at 8:15 a.m. Finnish time. A briefing for the media, analysts and investors will be organized on Tuesday, August 11, 2020 at 10:00 a.m. at restaurant Löyly, Hernesaarenranta 4, 00150 Helsinki. The presentation about NoHo Partners Plc's Q2/2020 financial performance, key events, the current state of business and

EcoOnline finds a perfect match in the UK to fuel further growth

EcoOnline expands and strengthens its comprehensive and easy to use health and safety SaaS solutions by acquiring Airsweb - a leading provider of premium Environmental, Health and Safety (EHS) software to large enterprise customers. Together, EcoOnline and Airsweb will be a leading EHS SaaS supplier for all customer sizes in Northern Europe.Airsweb is based in the UK. Their multi-country cloud-based platform AVA is designed for rapid deployment and known for its simplicity, configurability and ease of use. Airsweb have more than 90 large enterprise clients, with the total of 500,000 users

Tagrisso granted Breakthrough Therapy Designation in the US for the adjuvant treatment of patients with Stage IB-IIIA EGFR-mutated lung cancer

30 July 2020 07:05 BST Tagrisso granted Breakthrough Therapy Designation in the US for the adjuvant treatment of patients with Stage IB-IIIA EGFR-mutated lung cancer Designation based on unprecedented results from the Phase III ADAURA trialwhere Tagrisso reduced the risk of disease recurrence or death by c. 80% AstraZeneca's Tagrisso (osimertinib) has been granted Breakthrough Therapy Designation (BTD) in the US for the adjuvant treatment of patients with early-stage (IB, II and IIIA) epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC) after

Invitation to presentation in conjunction with Acroud's second quarter of 2020

On Thursday 13[th] August at 08:00 a.m. CET Acroud's interim report for the second quarter of 2020, will be published. At 10:00 a.m. the same day a presentation of Acroud's interim report for the second quarter of 2020, will be presented.CEO Robert Andersson and CFO Gustav Vadenbring will present the results, followed by a Q&A session. The presentation will be held in English and will be webcasted live through www.acroud.com or via https://tv.streamfabriken.com/acroud-q2-2020 The join the conference via phone, please dial-in using any of the numbers below: From Sweden: +46850558359

Risk Intelligence A/S signs an agreement for the Risk Intelligence System with a major Flag State

Risk Intelligence A/S (“Risk Intelligence” or "the Company") announces today that the company has signed an agreement with a major Flag State for the Risk Intelligence System (MaRisk+PortRisk).Every merchant ship must be registered to a flag state. The ship will follow the regulation of the flag state nation’s maritime law in the open sea and it will also conform to advisory notices for security, amongst other key topics.  Hence it is key that situational awareness is maintained by the Flag State. Jim Pascoe, Sales Director of Risk Intelligence says: “We really look forward to working

YIT to construct a new building for a secondary school and sports in Heinävesi, Finland

YIT Corporation Press release, July 30, 2020 at 10:00 a.m.YIT and the municipality of Heinävesi have reached an agreement on building a new secondary school and sport building in Heinävesi. The contract will be carried out as a turnkey contract and will include the demolition of the previous secondary school. The work will begin in July 2020 and end in December 2021. The value of the agreement is EUR 7.6 million. The new building will be the only secondary school in the municipality of Heinävesi, and, in 2021, there will be an estimated 80 secondary school students as well as 140 primary

Reminder: Invitation to Kongsberg Automotive's Q2 2020 Earnings Call

Kongsberg Automotive ASA will release its second quarter 2020 results on Thursday August 6th 2020 at 07:30 am CET. The company will host an earnings conference call for investors, analysts and media at 09:00 CET, on August 6th, which will include a review of the Q2 2020 presentation led by CEO Henning Jensen and CFO Norbert Loers. After the review, listeners have the opportunity to ask questions to the presenters. The Q2 earnings call will be available via web and audio, and to access the Earnings Call please choose one of the options below. Link to the Audio Webcast: https://

AZN: H1 2020 results

AstraZeneca PLC 30 July 2020 07:00 BST H1 2020 results A strong performance during the pandemic; a leader in the fight against COVID-19 During the COVID-19 global pandemic, AstraZeneca's priority was and will continue to be the safe supply of medicines to millions of patients. In the first half, revenue, profit and cash-flow continued to grow. This performance was supported by successful launches of new medicines[1] and more encouraging progress from the pipeline. The Company's focus on growth through innovation is designed to support a continuation of these trends. Pascal

Atlas Copco to acquire a mechanical contractor for the medical industry

Nacka, Sweden, July 30, 2020: Atlas Copco has agreed to acquire MEDGAS-Technik GmbH. The company is a manufacturer, distributor, installer and service provider of medical air and medical vacuum systems, pipeline equipment and medical supplies.MEDGAS is headquartered in Berndroth, Germany, and has 80 employees. The company has branch offices in Germany, Austria and Switzerland. In 2019 the company had a turnover of approximately MSEK 126 (MEUR12). “The company’s knowledge and product portfolio will strengthen our presence and accelerate our business development within medical gas in

EVOLUTION LAUNCHES INSTANT ROULETTE, A UNIQUE MULTI-WHEEL LIVE ROULETTE GAME

[PR] Evolution Gaming, leading provider of Live Casino solutions, has today launched its exclusive multi-wheel Instant Roulette. First unveiled at ICE 2020, Instant Roulette is another exciting addition to Evolution’s extensive range of online Live Roulette variants, which includes the award-winning titles Lightning Roulette and Immersive Roulette.In Instant Roulette, 12 individual, synchronised Auto Roulette wheels spin sequentially, with the balls dropping one after the other in the different wheels. As a consequence, players can play at a pace to suit themselves, because the key

Canadian Tire Dealer Association Selects Pricer as their Exclusive ESL System Vendor and Places First Initial Order

Pricer AB (publ) announces that Canadian Tire Dealer Association, CTDA, a dealer network of approximately 500 stores across Canada, have signed a Master Framework Agreement with Pricer as their exclusive supplier for Electronic Shelf Label (ESL) systems. The first order under this agreement amounts to about SEK 100 million, corresponding to an infrastructure order for all stores in the chain to be called off as installations are carried out over the next year, along with 38 stores partially or in full to be installed with the complete Pricer system before end of Q1 2021.The selection of

Dignitana strengthens operating capital through a loan from Adma Förvaltnings AB

Dignitana AB  announces that the Company has received an unsecured loan in the amount of 20 million SEK from Adma Förvaltnings AB . The loan will provide operating capital needed to support the Company’s aggressive growth strategy into 2021 focused on the United States, Europe, and Asia. Adma is the largest shareholder in the Company, holding 26 percent of Dignitana shares. The loan term is 5 months with an option to extend to end of Q1 2021 and is based at STIBOR +700 basis points.   This is information that Dignitana AB (publ)

DDM Holding AG: Q2 and half year report January – June 2020

Resilient portfolio and strategic investment in challenging environmentHighlights second quarter 2020 · Net collections amounted to EUR 13.3M (14.2)* · Cash EBITDA amounted to EUR 10.4M (11.0)* · Net loss for the period of EUR 0.7M (1.5)* · Cash on hand available for investment at the end of June 2020 was EUR 26M (12 at December 2019) · COVID-19 pandemic has had an adverse impact on global business and economic activity, significantly decreasing net collections that DDM received at the beginning of the second quarter, but gradually improved throughout the quarter as

Axolot Solutions Holding AB (publ) INTERIM REPORT January - June 2020

Several ongoing customer activities at the same time as Covid-19 affected the customers' long term investment decisionsSummary of the second quarter 2020 Financially     · Net sales amounted to 1 019 tsek (607 tsek for the corresponding quarter in 2019), as a consequence of more trial runs and customer cooperation activities, mainly in Sweden and Finland. This was the highest invoicing for Axolot so far, for a separate quarter. · Other revenues were 11 tsek (107). · Earnings before interest and tax became -5 309 tsek (-7 604), where the less negative results relate to higher

BIMobject: Interim Report April - June 2020

Financial summary · Net sales of MSEK 34.8 (34.4), +1%.  · Platform net sales of MSEK 26.2 (23.4), +12%.  · EBITDA of MSEK -14.6 (-33.3), corresponding to an EBITDA margin of -42% (-97%).  · Basic earnings per share amounted to SEK -0.16 (-0.29).  · Group cash flow* from operating activities of MSEK -4.2 (-28.4).  · The accumulated number of users in thousands increased by 32 percent to approximately 2,021 (1,542).  · The accumulated number of downloads amounted to 60.4 million (40.1).  · The number of brands amounted to 1,874 (1,553). Significant

DDM Debt AB: Q2 and half year report January – June 2020

Resilient portfolio and strategic investment in challenging environmentHighlights second quarter 2020 · Net collections amounted to EUR 12.1M (13.5)* · Cash EBITDA amounted to EUR 9.7M (10.5)* · Net loss for the period of EUR 1.2M (2.2)* · Cash on hand available for investment at the end of June 2020 was EUR 24M (11 at December 2019) · COVID-19 pandemic has had an adverse impact on global business and economic activity, significantly decreasing net collections that the DDM Debt Group received at the beginning of the second quarter, but gradually improved throughout the

Appointment of Chief Medical Officer at Moberg Pharma

STOCKHOLM, July 30[th], 2020, Moberg Pharma AB (OMX: MOB) announces the appointment of Dr Cindy Wong as Chief Medical Officer of Moberg Pharma. Dr Wong will during the fall be joining the management team at Moberg Pharma coming from a previous position as Vice President and Head of Global Clinical Development at Metz Pharmaceuticals GmbH.Moberg Pharma is pleased to announce the appointment of Dr Cindy Wong as Chief Medical Officer. Dr Wong brings extensive international experience in clinical development and registration of new products in a number of treatment areas including Dermatology.

Nordic Nanovector Announces EU Patent Granted Covering the Use of Alpha37

Oslo, Norway, 30 July 2020 Nordic Nanovector ASA (OSE: NANO) is pleased to announce the grant of an EU patent covering the use of Alpha37 for the treatment of Chronic Lymphocytic Leukemia (CLL) and non-Hodgkin’s lymphoma (NHL). Alpha37 is an investigational radioimmunoconjugate developed by Nordic Nanovector in collaboration with Orano Med comprising a proprietary chimeric CD37-targeting antibody conjugated to the alpha-particle generating radionuclide lead-212. Alpha37 has completed preclinical development, during which it demonstrated promising immunogenicity, biodistribution and

Thailand ranked number one on the Global COVID-19 Recovery Index

The Kingdom comes in first out of 184 nations worldwide for its effective handling of the virus .   Thailand has ranked number one in the world out of 184 countries for its ongoing COVID-19 recovery effort, according to the Global COVID-19 Index  (GCI). Published on 28 July, Thailand received an index score of 82.06, putting it on top of the global chart as an example of best practices in tackling the ongoing global pandemic. As of 29 July 2020, the number of confirmed cases in Thailand stood at 3,298, with 129 currently being treated, while 3,

There are no items matching the current filter
There are no more items matching the current filter
Back to top